These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27462958)

  • 21. Differential localization and anabolic responsiveness of mTOR complexes in human skeletal muscle in response to feeding and exercise.
    Hodson N; McGlory C; Oikawa SY; Jeromson S; Song Z; Rüegg MA; Hamilton DL; Phillips SM; Philp A
    Am J Physiol Cell Physiol; 2017 Dec; 313(6):C604-C611. PubMed ID: 28971834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. mTORC2 Assembly Is Regulated by USP9X-Mediated Deubiquitination of RICTOR.
    Wrobel L; Siddiqi FH; Hill SM; Son SM; Karabiyik C; Kim H; Rubinsztein DC
    Cell Rep; 2020 Dec; 33(13):108564. PubMed ID: 33378666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of rictor as a novel substrate of Polo-like kinase 1.
    Shao T; Liu X
    Cell Cycle; 2015; 14(5):755-60. PubMed ID: 25714006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repression of Human Papillomavirus Oncogene Expression under Hypoxia Is Mediated by PI3K/mTORC2/AKT Signaling.
    Bossler F; Kuhn BJ; Günther T; Kraemer SJ; Khalkar P; Adrian S; Lohrey C; Holzer A; Shimobayashi M; Dürst M; Mayer A; Rösl F; Grundhoff A; Krijgsveld J; Hoppe-Seyler K; Hoppe-Seyler F
    mBio; 2019 Feb; 10(1):. PubMed ID: 30755508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two conserved glycine residues in mammalian and
    Pergolizzi B; Panuzzo C; Ali MS; Lo Iacono M; Levra Levron C; Ponzone L; Prelli M; Cilloni D; Calautti E; Bozzaro S; Bracco E
    J Cell Sci; 2019 Nov; 132(22):. PubMed ID: 31653780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship.
    Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH
    Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The underlying mechanism of proinflammatory NF-κB activation by the mTORC2/Akt/IKKα pathway during skin aging.
    Choi YJ; Moon KM; Chung KW; Jeong JW; Park D; Kim DH; Yu BP; Chung HY
    Oncotarget; 2016 Aug; 7(33):52685-52694. PubMed ID: 27486771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling.
    Yoon MS
    Nutrients; 2017 Oct; 9(11):. PubMed ID: 29077002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Levels of Rictor Prevent Mutant Huntingtin-Induced Neuronal Degeneration.
    Creus-Muncunill J; Rué L; Alcalá-Vida R; Badillos-Rodríguez R; Romaní-Aumedes J; Marco S; Alberch J; Perez-Otaño I; Malagelada C; Pérez-Navarro E
    Mol Neurobiol; 2018 Oct; 55(10):7728-7742. PubMed ID: 29460266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammation-induced mTORC2-Akt-mTORC1 signaling promotes macrophage foam cell formation.
    Banerjee D; Sinha A; Saikia S; Gogoi B; Rathore AK; Das AS; Pal D; Buragohain AK; Dasgupta S
    Biochimie; 2018 Aug; 151():139-149. PubMed ID: 29883748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PI3K/Akt promotes feedforward mTORC2 activation through IKKα.
    Dan HC; Antonia RJ; Baldwin AS
    Oncotarget; 2016 Apr; 7(16):21064-75. PubMed ID: 27027448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD146 Regulates Growth Factor-Induced mTORC2 Activity Independent of the PI3K and mTORC1 Pathways.
    Xu W; Hua H; Chiu YH; Li G; Zhi H; Yu Z; Ren F; Luo Y; Cui W
    Cell Rep; 2019 Oct; 29(5):1311-1322.e5. PubMed ID: 31665642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers.
    Morrison Joly M; Hicks DJ; Jones B; Sanchez V; Estrada MV; Young C; Williams M; Rexer BN; Sarbassov dos D; Muller WJ; Brantley-Sieders D; Cook RS
    Cancer Res; 2016 Aug; 76(16):4752-64. PubMed ID: 27197158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rictor ablation in BMSCs inhibits bone metastasis of TM40D cells by attenuating osteolytic destruction and CAF formation.
    Liu Z; Wang H; He J; Yuan X; Sun W
    Int J Biol Sci; 2019; 15(11):2448-2460. PubMed ID: 31595162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rictor/mTORC2 loss in osteoblasts impairs bone mass and strength.
    Liu DM; Zhao L; Liu TT; Jiao PL; Zhao DD; Shih MS; Tao B; Sun LH; Zhao HY; Liu JM
    Bone; 2016 Sep; 90():50-8. PubMed ID: 27262777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual PI3K/mTOR Inhibitors Induce Rapid Overactivation of the MEK/ERK Pathway in Human Pancreatic Cancer Cells through Suppression of mTORC2.
    Soares HP; Ming M; Mellon M; Young SH; Han L; Sinnet-Smith J; Rozengurt E
    Mol Cancer Ther; 2015 Apr; 14(4):1014-23. PubMed ID: 25673820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.
    Li N; Xue W; Yuan H; Dong B; Ding Y; Liu Y; Jiang M; Kan S; Sun T; Ren J; Pan Q; Li X; Zhang P; Hu G; Wang Y; Wang X; Li Q; Qin J
    J Clin Invest; 2017 Apr; 127(4):1284-1302. PubMed ID: 28319045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of 14-3-3 binding to Rictor of mTORC2 for Akt phosphorylation at Ser473 is regulated by selenoprotein W.
    Jeon YH; Park YH; Kwon JH; Lee JH; Kim IY
    Biochim Biophys Acta; 2013 Oct; 1833(10):2135-42. PubMed ID: 23680186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects.
    Jhanwar-Uniyal M; Amin AG; Cooper JB; Das K; Schmidt MH; Murali R
    Adv Biol Regul; 2017 May; 64():39-48. PubMed ID: 28189457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. mTORC1/2 inhibitor and curcumin induce apoptosis through lysosomal membrane permeabilization-mediated autophagy.
    Seo SU; Woo SM; Lee HS; Kim SH; Min KJ; Kwon TK
    Oncogene; 2018 Sep; 37(38):5205-5220. PubMed ID: 29849119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.